The chemical class known as RPL26L1 activators encompasses a group of compounds that can upregulate the expression or enhance the function of the ribosomal protein L26 like 1 (RPL26L1). These chemicals can interact with various cellular pathways to modulate the activity of RPL26L1, and they operate through distinct mechanisms of action, each impacting the ribosomal protein indirectly by altering the cellular environment or the expression of genes. The primary mode of action for these activators involves either inhibition or facilitation of key cellular processes, such as DNA methylation, histone acetylation, and protein synthesis, which are integral to the regulation of gene expression. By modulating these processes, the activators can influence the transcriptional and translational machinery of the cell, thereby playing a role in the regulation of ribosomal proteins including RPL26L1.
In the context of ribosome assembly and function, these compounds can have a significant impact. For instance, some activators work by inhibiting enzymes responsible for DNA methylation or histone deacetylation, leading to a more relaxed chromatin structure and an increased rate of transcription. This action can result in enhanced expression of a broad array of genes, among which are those coding for ribosomal proteins like RPL26L1. Other compounds in this class may inhibit the mTOR signaling pathway, which is closely associated with protein synthesis and cell growth, thereby affecting the synthesis of ribosomal proteins. Additionally, some activators interfere with the protein synthesis machinery directly, either by inhibiting translation elongation or by causing premature chain termination, which can trigger a compensatory increase in ribosomal protein production. Through these diverse yet interconnected pathways, RPL26L1 activators can play a role in the complex regulation of ribosome biogenesis and function, which is central to cellular metabolism and homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Inhibits DNA methylation, which can lead to the upregulation of genes including those coding for ribosomal proteins, thereby could possibly activate RPL26L1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor that can result in a more open chromatin structure, potentially increasing transcription of ribosomal protein genes and could possibly activate RPL26L1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can lead to changes in protein synthesis and could possibly activate RPL26L1 production as a compensatory mechanism. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis, which can cause feedback upregulation of ribosomal protein gene expression and could possibly activate RPL26L1. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and inhibits RNA polymerase, which can lead to altered ribosomal protein gene expression and could possibly activate RPL26L1. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Causes premature chain termination during protein synthesis, potentially affecting ribosomal protein levels and could possibly activate RPL26L1. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Inhibits inosine monophosphate dehydrogenase, potentially affecting cell proliferation and ribosomal protein levels, and could possibly activate RPL26L1. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Inhibits the initial elongation step of protein synthesis, which could lead to changes in ribosomal protein expression and could possibly activate RPL26L1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits peptidyl transferase activity of the ribosome, potentially affecting ribosome assembly and function, and could possibly activate RPL26L1. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
An Hsp90 inhibitor that can influence various signaling pathways, potentially affecting ribosomal protein levels and could possibly activate RPL26L1. | ||||||